Who owns the REVELATION PHARMA trademark?

The REVELATION PHARMA trademark is owned by REVELATION PHARMA MANAGEMENT , LLC.

What is the serial number for REVELATION PHARMA?

The USPTO serial number for REVELATION PHARMA is 97904092.

What is the registration number for REVELATION PHARMA?

REVELATION PHARMA is registered under USPTO registration number 0.

REV

USPTO Trademark Record

PENDING

REVELATION PHARMA

Q: What class is the REVELATION PHARMA trademark registered in?

The REVELATION PHARMA trademark is registered in Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

SN 97904092·Reg 0·Filed Apr 24, 2023

Owner REVELATION PHARMA MANAGEMENT , LLC

Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

REVELATION PHARMA (Serial No. 97904092), Registration No. 0, is a pending US trademark filed on Apr 24, 2023 by REVELATION PHARMA MANAGEMENT , LLC. This trademark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Office Action response: October 28, 20269 days remaining

Mark Intelligence

REVELATION PHARMA (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Scientific and technological servi....

FILED

Apr 24, 2023

SERIAL

97904092

REG#

Owner

Applicant

REVELATION PHARMA MANAGEMENT , LLC

Entity

LLC

State

Address

3330 CHASTAIN MEADOW PKWY NW, SUITE 101, KENNESAW, GA, 30144

Country

Attorney

NameDeborah L. Lively

Law firm

Deborah L. Lively Pierson Ferdinand LLP

Docket

20943-T001US

Address

711 S. Cedar Ridge Dr. #380308, Duncanville, TX 75138, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateApr 24, 2023

Serial Number97904092

Registration No.0

Status DateJul 28, 2026

Mark TypeDesign with words

Attorney Docket20943-T001US

Status DescriptionLive and pending, final refusal mailed

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

FINAL REFUSAL WRITTEN

Jul 28, 2026

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jul 28, 2026

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 28, 2026

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Jul 08, 2026

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 08, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 08, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jan 28, 2026

ASSIGNED TO EXAMINER